How big is Cross Country Healthcare, Inc.?

As of Jun 18, Cross Country Healthcare, Inc. has a market capitalization of 457.33 million and reported net sales of 1,258.24 million with a net profit of -17.73 million over the latest four quarters. Shareholder's Funds are at 418.96 million and Total Assets at 589.25 million as of Dec 24.

As of Jun 18, Cross Country Healthcare, Inc. has a market capitalization of 457.33 million, categorizing it as a Micro Cap company.<BR><BR>As of Jun 18, the sum of net sales for the latest four quarters is 1,258.24 million, while the sum of net profit for the same period is -17.73 million.<BR><BR>As of Dec 24, the reporting period shows Shareholder's Funds at 418.96 million and Total Assets at 589.25 million.

What does Cross Country Healthcare, Inc. do?

Cross Country Healthcare, Inc. provides healthcare recruiting, staffing, and workforce solutions, operating as a micro-cap company with a market cap of $457.33 million. As of March 2025, it reported net sales of $293 million but no net profit.

Overview: <BR>Cross Country Healthcare, Inc. is engaged in providing healthcare recruiting, staffing, and workforce solutions within the diversified commercial services industry, categorized as a micro-cap company.<BR><BR>Financial Snapshot: <BR>Most recent Net Sales: 293 Million (Quarterly Results - Mar 2025) <BR>Most recent Net Profit: 0 Million (Quarterly Results - Mar 2025) <BR>Market-cap: USD 457.33 Million (Micro Cap) <BR><BR>Key Metrics: <BR>P/E: NA (Loss Making) <BR>Industry P/E: NA <BR>Dividend Yield: 0.00% <BR>Debt Equity: -0.19 <BR>Return on Equity: -0.65% <BR>Price to Book: 1.09 <BR><BR>Contact Details: <BR>Address: 6551 PARK OF COMMERCE BOULEVARD, N.W., BOCA RATON FL: 33487 <BR>Tel: ['1 334 878247', '1 800 3472264'] <BR>Fax: 1 302 6365454 <BR>Website: https://www.crosscountryhealthcare.com/

Should I buy, sell or hold Cross Country Healthcare, Inc.?

Who are in the management team of Cross Country Healthcare, Inc.?

As of March 2022, the management team of Cross Country Healthcare, Inc. includes Mr. Thomas Dircks (Independent Chairman), Mr. Kevin Clark (CEO), Mr. W. Larry Cash (Lead Independent Director), and several independent directors including Janice Nevin, Gale Fitzgerald, Darrell Freeman, and Mark Perlberg. They oversee the company's operations and strategic direction.

As of March 2022, the management team of Cross Country Healthcare, Inc. includes the following individuals:<BR><BR>- Mr. Thomas Dircks, Independent Chairman of the Board<BR>- Mr. Kevin Clark, President, Chief Executive Officer, and Director<BR>- Mr. W. Larry Cash, Lead Independent Director<BR>- Janice Nevin, Director<BR>- Ms. Gale Fitzgerald, Independent Director<BR>- Mr. Darrell Freeman, Independent Director<BR>- Mr. Mark Perlberg, Independent Director<BR><BR>This team is responsible for overseeing the company's operations and strategic direction.

Is Cross Country Healthcare, Inc. overvalued or undervalued?

As of November 6, 2024, Cross Country Healthcare, Inc. is considered overvalued and risky due to negative returns on capital and equity, high EV to EBITDA ratio compared to peers, and significant underperformance against the S&P 500.

As of 6 November 2024, the valuation grade for Cross Country Healthcare, Inc. has moved from expensive to risky, indicating a shift in perception regarding its financial health. The company is currently considered overvalued, particularly given its negative return on capital employed (ROCE) of -1.62% and return on equity (ROE) of -0.65%. Key valuation ratios include a price-to-book value of 1.01, an EV to EBITDA ratio of 26.84, and an EV to sales ratio of 0.27, which suggest that the company is not generating sufficient returns relative to its valuation.<BR><BR>When compared to peers, Cross Country Healthcare's EV to EBITDA ratio of 26.84 is significantly higher than AMN Healthcare Services, Inc. at 7.71 and Kforce, Inc. at 33.55, indicating a premium valuation despite its losses. Additionally, the company's stock has underperformed against the S&P 500, with a year-to-date return of -24.78% compared to the index's 12.22%, reinforcing the notion that it may be overvalued in the current market environment.

Is Cross Country Healthcare, Inc. technically bullish or bearish?

As of September 11, 2025, Cross Country Healthcare, Inc. shows a mildly bearish trend due to daily moving averages, despite some bullish indicators, and has underperformed the S&P 500 with year-to-date and one-year returns of -24.78% and -7.77%, respectively.

As of 11 September 2025, the technical trend for Cross Country Healthcare, Inc. has changed from sideways to mildly bearish. The current stance is mildly bearish, primarily driven by the daily moving averages indicating a bearish signal. While the weekly MACD and KST are mildly bullish, the overall sentiment is tempered by the monthly Bollinger Bands showing a mildly bearish trend. Additionally, the company has underperformed against the S&P 500 in the year-to-date and one-year periods, with returns of -24.78% and -7.77% respectively, compared to the S&P 500's returns of 12.22% and 17.14%.